These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 25739386

  • 1. Double Stranded RNA-Dependent Protein Kinase is Necessary for TNF-α-Induced Osteoclast Formation In Vitro and In Vivo.
    Shinohara H, Teramachi J, Okamura H, Yang D, Nagata T, Haneji T.
    J Cell Biochem; 2015 Sep; 116(9):1957-67. PubMed ID: 25739386
    [Abstract] [Full Text] [Related]

  • 2. Double stranded RNA-dependent protein kinase is involved in osteoclast differentiation of RAW264.7 cells in vitro.
    Teramachi J, Morimoto H, Baba R, Doi Y, Hirashima K, Haneji T.
    Exp Cell Res; 2010 Nov 15; 316(19):3254-62. PubMed ID: 20728438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E, Aoki Y, Yoshimatsu M, Nishishita K, Iwatake M, Fukuma Y, Okamoto K, Tanaka T, Tsukuba T.
    Phytomedicine; 2016 Jul 15; 23(8):828-37. PubMed ID: 27288918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.
    Yokota K, Sato K, Miyazaki T, Kitaura H, Kayama H, Miyoshi F, Araki Y, Akiyama Y, Takeda K, Mimura T.
    Arthritis Rheumatol; 2014 Jan 15; 66(1):121-9. PubMed ID: 24431283
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 11. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
    Kohara H, Kitaura H, Fujimura Y, Yoshimatsu M, Morita Y, Eguchi T, Masuyama R, Yoshida N.
    Immunol Lett; 2011 Jun 30; 137(1-2):53-61. PubMed ID: 21338623
    [Abstract] [Full Text] [Related]

  • 12. Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1.
    Yang CR, Lai CC.
    Shock; 2010 Jun 30; 33(6):662-7. PubMed ID: 19953004
    [Abstract] [Full Text] [Related]

  • 13. Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression.
    Karieb S, Fox SW.
    J Cell Biochem; 2011 Feb 30; 112(2):476-87. PubMed ID: 21268069
    [Abstract] [Full Text] [Related]

  • 14. PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo.
    Teramachi J, Inagaki Y, Shinohara H, Okamura H, Yang D, Ochiai K, Baba R, Morimoto H, Nagata T, Haneji T.
    Oral Dis; 2017 Mar 30; 23(2):181-188. PubMed ID: 27718290
    [Abstract] [Full Text] [Related]

  • 15. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 16. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M, Suzuki R, Shirataki Y, Sakagami H, Tamura N, Tomomura A.
    PLoS One; 2015 Sep 15; 10(6):e0130174. PubMed ID: 26083531
    [Abstract] [Full Text] [Related]

  • 17. Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation.
    Kagiya T, Nakamura S.
    J Periodontal Res; 2013 Jun 15; 48(3):373-85. PubMed ID: 23078176
    [Abstract] [Full Text] [Related]

  • 18. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 15; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 19. Roles of PKR in differentiation and apoptosis of bone-related cells.
    Haneji T.
    Anat Sci Int; 2017 Jun 15; 92(3):313-319. PubMed ID: 27987116
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.